Videos |view more
Dr. Michael R. Bishop, professor of medicine, describes the scientific background and early results for CAR T cell therapy and then summarizes some of the most recent clinical data supporting the use of CAR T cells in hematologic malignancies.
Dr. Akash Patnaik, assistant professor of medicine, discusses the rationale for PI3k as a therapeutic target in prostate cancer and the mechanistic strategies to overcome de novo and acquired resistance to single agent PI3K inhibitors ...
Dr. Suzanne Conzen, professor of medicine, discusses white adipose tissue, autologous breast reconstruction and fat depot secretome. Dr. Conzen also examines cell proliferation and death assays.
Chief, Section of Gynecologic Oncology, Dr. Diane Yamada, gives an update on the prevention and treatment of gynecologic malignancies.